A. Patient’s information and medical history regarding DM | n (or %)* |
Age | 12 |
Pregnancy/lactation | 0 |
Duration of DM | 0 |
FBG and RBG readings | 33 |
Frequency of routine DM clinic visits | 0 |
Other chronic medical condition(s) | 0 |
Chronic medication(s) | 22 |
Adherence to diet and physical activity | 20 |
Controlled/uncontrolled DM before the onset of new symptoms | 17 |
Presence of fruity-smelling breath | 0 |
Constant/fluctuating insulin doses before the onset of new symptoms | 0 |
None of the above was obtained by the pharmacist | 61 |
B. Assessment of COVID-19 exposure | Â |
Occupation (to rule out high-risk occupations such as HCP and LTCF personnel) | 4 |
Residence and members sharing living | 6 |
Close contact with someone with symptoms, or diagnosed or tested positive for COVID-19 within 2 weeks before feeling sick | 29 |
Travel history | 0 |
Attending a social gathering, or being in crowded indoor settings | 7 |
None of the above was obtained by the pharmacist | 70 |
C. Assessment of COVID-19-related symptoms and treatments | Â |
Symptoms of COVID-19 (e.g., cough, shortness of breath or difficulty breathing, fever or chills, muscle or body aches, recent loss of taste or smell, vomiting or diarrhea) | 57 |
Onset and duration of symptoms | 21 |
Life-threatening symptoms | 7 |
Medications used to manage symptoms | 10 |
History of flu vaccination | 3 |
None of the above was obtained by the pharmacist | 41 |